nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—ABCB1—Desloratadine—allergic rhinitis	0.0289	0.139	CbGbCtD
Crizotinib—CYP3A4—Flunisolide—allergic rhinitis	0.0173	0.0831	CbGbCtD
Crizotinib—ABCB1—Loratadine—allergic rhinitis	0.0166	0.0796	CbGbCtD
Crizotinib—CYP3A4—Olopatadine—allergic rhinitis	0.0163	0.0781	CbGbCtD
Crizotinib—ABCB1—Methylprednisolone—allergic rhinitis	0.0152	0.0728	CbGbCtD
Crizotinib—CYP3A5—Hydrocortisone—allergic rhinitis	0.0142	0.0681	CbGbCtD
Crizotinib—CYP3A4—Loratadine—allergic rhinitis	0.00993	0.0477	CbGbCtD
Crizotinib—CYP3A4—Montelukast—allergic rhinitis	0.00993	0.0477	CbGbCtD
Crizotinib—ABCB1—Betamethasone—allergic rhinitis	0.00986	0.0474	CbGbCtD
Crizotinib—ABCB1—Prednisolone—allergic rhinitis	0.00973	0.0467	CbGbCtD
Crizotinib—ABCB1—Hydrocortisone—allergic rhinitis	0.00922	0.0443	CbGbCtD
Crizotinib—CYP3A4—Methylprednisolone—allergic rhinitis	0.00908	0.0436	CbGbCtD
Crizotinib—CYP3A5—Dexamethasone—allergic rhinitis	0.00881	0.0423	CbGbCtD
Crizotinib—CYP3A4—Triamcinolone—allergic rhinitis	0.00688	0.0331	CbGbCtD
Crizotinib—ROS1—respiratory system—allergic rhinitis	0.0061	0.025	CbGeAlD
Crizotinib—CYP3A4—Betamethasone—allergic rhinitis	0.00591	0.0284	CbGbCtD
Crizotinib—CYP3A4—Prednisolone—allergic rhinitis	0.00583	0.028	CbGbCtD
Crizotinib—ABCB1—Dexamethasone—allergic rhinitis	0.00573	0.0275	CbGbCtD
Crizotinib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00552	0.0265	CbGbCtD
Crizotinib—CYP3A4—Dexamethasone—allergic rhinitis	0.00344	0.0165	CbGbCtD
Crizotinib—ROS1—lung—allergic rhinitis	0.00324	0.0133	CbGeAlD
Crizotinib—NEK9—respiratory system—allergic rhinitis	0.00303	0.0124	CbGeAlD
Crizotinib—PRKD1—respiratory system—allergic rhinitis	0.00276	0.0113	CbGeAlD
Crizotinib—PTK2—exocrine gland—allergic rhinitis	0.00257	0.0106	CbGeAlD
Crizotinib—TXK—respiratory system—allergic rhinitis	0.00245	0.0101	CbGeAlD
Crizotinib—MET—respiratory system—allergic rhinitis	0.0023	0.00943	CbGeAlD
Crizotinib—CDK7—respiratory system—allergic rhinitis	0.00222	0.00912	CbGeAlD
Crizotinib—EPHA8—eye—allergic rhinitis	0.00222	0.00911	CbGeAlD
Crizotinib—DSTYK—bronchus—allergic rhinitis	0.00213	0.00875	CbGeAlD
Crizotinib—MET—eye—allergic rhinitis	0.0021	0.00861	CbGeAlD
Crizotinib—PLK4—respiratory system—allergic rhinitis	0.002	0.00821	CbGeAlD
Crizotinib—TESK1—Loxapine—Cyproheptadine—allergic rhinitis	0.00196	0.24	CbGdCrCtD
Crizotinib—ACVR1B—eye—allergic rhinitis	0.00194	0.00796	CbGeAlD
Crizotinib—EPHA3—eye—allergic rhinitis	0.00194	0.00796	CbGeAlD
Crizotinib—MET—epithelium—allergic rhinitis	0.00192	0.00788	CbGeAlD
Crizotinib—MET—bronchus—allergic rhinitis	0.00189	0.00776	CbGeAlD
Crizotinib—ALK—respiratory system—allergic rhinitis	0.00188	0.00771	CbGeAlD
Crizotinib—MAP3K19—respiratory system—allergic rhinitis	0.00184	0.00755	CbGeAlD
Crizotinib—MET—skin of body—allergic rhinitis	0.00182	0.00749	CbGeAlD
Crizotinib—IGF1R—respiratory system—allergic rhinitis	0.0018	0.00741	CbGeAlD
Crizotinib—TIE1—respiratory system—allergic rhinitis	0.00175	0.00721	CbGeAlD
Crizotinib—EPHA5—eye—allergic rhinitis	0.00172	0.00704	CbGeAlD
Crizotinib—IGF1R—eye—allergic rhinitis	0.00165	0.00677	CbGeAlD
Crizotinib—LIMK2—respiratory system—allergic rhinitis	0.00161	0.00663	CbGeAlD
Crizotinib—NEK9—lung—allergic rhinitis	0.00161	0.0066	CbGeAlD
Crizotinib—STK3—eye—allergic rhinitis	0.0016	0.00658	CbGeAlD
Crizotinib—ACVR1—respiratory system—allergic rhinitis	0.0016	0.00656	CbGeAlD
Crizotinib—FLT3—respiratory system—allergic rhinitis	0.0016	0.00656	CbGeAlD
Crizotinib—TESK1—eye—allergic rhinitis	0.00155	0.00636	CbGeAlD
Crizotinib—FER—bronchus—allergic rhinitis	0.00155	0.00635	CbGeAlD
Crizotinib—BMPR1B—epithelium—allergic rhinitis	0.00154	0.00631	CbGeAlD
Crizotinib—TNK1—bronchus—allergic rhinitis	0.00153	0.00628	CbGeAlD
Crizotinib—BMPR1B—bronchus—allergic rhinitis	0.00151	0.00622	CbGeAlD
Crizotinib—MAP4K1—bronchus—allergic rhinitis	0.00151	0.00622	CbGeAlD
Crizotinib—IGF1R—epithelium—allergic rhinitis	0.00151	0.00619	CbGeAlD
Crizotinib—MERTK—eye—allergic rhinitis	0.00151	0.00619	CbGeAlD
Crizotinib—TYRO3—skin of body—allergic rhinitis	0.00149	0.00613	CbGeAlD
Crizotinib—DCLK1—trachea—allergic rhinitis	0.00149	0.0061	CbGeAlD
Crizotinib—TIE1—epithelium—allergic rhinitis	0.00147	0.00602	CbGeAlD
Crizotinib—PRKD1—lung—allergic rhinitis	0.00147	0.00602	CbGeAlD
Crizotinib—MAP3K12—eye—allergic rhinitis	0.00146	0.00599	CbGeAlD
Crizotinib—ACVR1—eye—allergic rhinitis	0.00146	0.00599	CbGeAlD
Crizotinib—PTK2B—respiratory system—allergic rhinitis	0.00145	0.00597	CbGeAlD
Crizotinib—STK3—bronchus—allergic rhinitis	0.00144	0.00593	CbGeAlD
Crizotinib—IGF1R—skin of body—allergic rhinitis	0.00143	0.00589	CbGeAlD
Crizotinib—PRKD3—lung—allergic rhinitis	0.00141	0.00579	CbGeAlD
Crizotinib—TESK1—bronchus—allergic rhinitis	0.0014	0.00573	CbGeAlD
Crizotinib—FER—trachea—allergic rhinitis	0.00139	0.0057	CbGeAlD
Crizotinib—DSTYK—lung—allergic rhinitis	0.00138	0.00565	CbGeAlD
Crizotinib—TNK1—trachea—allergic rhinitis	0.00137	0.00564	CbGeAlD
Crizotinib—LTK—lung—allergic rhinitis	0.00134	0.00552	CbGeAlD
Crizotinib—CASK—lung—allergic rhinitis	0.00134	0.00552	CbGeAlD
Crizotinib—PTK2—respiratory system—allergic rhinitis	0.00134	0.0055	CbGeAlD
Crizotinib—TBK1—respiratory system—allergic rhinitis	0.00134	0.0055	CbGeAlD
Crizotinib—TYK2—respiratory system—allergic rhinitis	0.00133	0.00546	CbGeAlD
Crizotinib—LIMK2—bronchus—allergic rhinitis	0.00133	0.00545	CbGeAlD
Crizotinib—RIPK2—eye—allergic rhinitis	0.00132	0.00541	CbGeAlD
Crizotinib—MAP3K12—bronchus—allergic rhinitis	0.00131	0.0054	CbGeAlD
Crizotinib—ACVR1—bronchus—allergic rhinitis	0.00131	0.0054	CbGeAlD
Crizotinib—MAPK7—lung—allergic rhinitis	0.0013	0.00535	CbGeAlD
Crizotinib—TXK—lung—allergic rhinitis	0.0013	0.00535	CbGeAlD
Crizotinib—FES—lung—allergic rhinitis	0.00129	0.00529	CbGeAlD
Crizotinib—RPS6KB1—respiratory system—allergic rhinitis	0.00129	0.00529	CbGeAlD
Crizotinib—FGR—respiratory system—allergic rhinitis	0.00128	0.00526	CbGeAlD
Crizotinib—AXL—respiratory system—allergic rhinitis	0.00127	0.00524	CbGeAlD
Crizotinib—TESK1—trachea—allergic rhinitis	0.00125	0.00515	CbGeAlD
Crizotinib—STK35—skin of body—allergic rhinitis	0.00124	0.00511	CbGeAlD
Crizotinib—BMP2K—bronchus—allergic rhinitis	0.00124	0.00509	CbGeAlD
Crizotinib—TBK1—eye—allergic rhinitis	0.00122	0.00502	CbGeAlD
Crizotinib—MET—lung—allergic rhinitis	0.00122	0.005	CbGeAlD
Crizotinib—EPHB4—respiratory system—allergic rhinitis	0.00122	0.005	CbGeAlD
Crizotinib—TYK2—eye—allergic rhinitis	0.00121	0.00499	CbGeAlD
Crizotinib—JAK2—respiratory system—allergic rhinitis	0.00121	0.00497	CbGeAlD
Crizotinib—RIPK2—epithelium—allergic rhinitis	0.00121	0.00495	CbGeAlD
Crizotinib—EPHA2—respiratory system—allergic rhinitis	0.0012	0.00491	CbGeAlD
Crizotinib—LIMK2—trachea—allergic rhinitis	0.00119	0.0049	CbGeAlD
Crizotinib—NUAK2—trachea—allergic rhinitis	0.00119	0.00488	CbGeAlD
Crizotinib—RIPK2—bronchus—allergic rhinitis	0.00119	0.00487	CbGeAlD
Crizotinib—ACVR1—trachea—allergic rhinitis	0.00118	0.00484	CbGeAlD
Crizotinib—CDK7—lung—allergic rhinitis	0.00118	0.00484	CbGeAlD
Crizotinib—RPS6KB1—eye—allergic rhinitis	0.00118	0.00483	CbGeAlD
Crizotinib—TAOK2—lung—allergic rhinitis	0.00117	0.0048	CbGeAlD
Crizotinib—TEK—respiratory system—allergic rhinitis	0.00117	0.00479	CbGeAlD
Crizotinib—AXL—eye—allergic rhinitis	0.00116	0.00478	CbGeAlD
Crizotinib—EPHA4—bronchus—allergic rhinitis	0.00115	0.00471	CbGeAlD
Crizotinib—RIPK2—skin of body—allergic rhinitis	0.00115	0.00471	CbGeAlD
Crizotinib—EPHA3—lung—allergic rhinitis	0.00113	0.00463	CbGeAlD
Crizotinib—ACVR1B—lung—allergic rhinitis	0.00113	0.00463	CbGeAlD
Crizotinib—PTK2—epithelium—allergic rhinitis	0.00112	0.00459	CbGeAlD
Crizotinib—TBK1—bronchus—allergic rhinitis	0.0011	0.00452	CbGeAlD
Crizotinib—PTK2—bronchus—allergic rhinitis	0.0011	0.00452	CbGeAlD
Crizotinib—TYK2—bronchus—allergic rhinitis	0.00109	0.00449	CbGeAlD
Crizotinib—IRAK1—bronchus—allergic rhinitis	0.00108	0.00444	CbGeAlD
Crizotinib—YES1—respiratory system—allergic rhinitis	0.00108	0.00442	CbGeAlD
Crizotinib—RPS6KB1—epithelium—allergic rhinitis	0.00108	0.00442	CbGeAlD
Crizotinib—JAK3—lung—allergic rhinitis	0.00107	0.00441	CbGeAlD
Crizotinib—DCLK1—lung—allergic rhinitis	0.00107	0.00439	CbGeAlD
Crizotinib—STK10—respiratory system—allergic rhinitis	0.00107	0.00438	CbGeAlD
Crizotinib—RIPK2—trachea—allergic rhinitis	0.00107	0.00438	CbGeAlD
Crizotinib—PTK2—skin of body—allergic rhinitis	0.00106	0.00437	CbGeAlD
Crizotinib—TAOK3—respiratory system—allergic rhinitis	0.00106	0.00437	CbGeAlD
Crizotinib—PLK4—lung—allergic rhinitis	0.00106	0.00436	CbGeAlD
Crizotinib—RPS6KB1—bronchus—allergic rhinitis	0.00106	0.00435	CbGeAlD
Crizotinib—TYK2—skin of body—allergic rhinitis	0.00106	0.00434	CbGeAlD
Crizotinib—STK4—lung—allergic rhinitis	0.00105	0.00433	CbGeAlD
Crizotinib—LCK—bronchus—allergic rhinitis	0.00105	0.00433	CbGeAlD
Crizotinib—SRC—respiratory system—allergic rhinitis	0.00104	0.00425	CbGeAlD
Crizotinib—EPHA4—trachea—allergic rhinitis	0.00103	0.00423	CbGeAlD
Crizotinib—EPHB4—epithelium—allergic rhinitis	0.00102	0.00418	CbGeAlD
Crizotinib—AXL—skin of body—allergic rhinitis	0.00101	0.00416	CbGeAlD
Crizotinib—JAK2—epithelium—allergic rhinitis	0.00101	0.00415	CbGeAlD
Crizotinib—SLK—bronchus—allergic rhinitis	0.00101	0.00415	CbGeAlD
Crizotinib—EPHB4—bronchus—allergic rhinitis	0.001	0.00412	CbGeAlD
Crizotinib—EPHA2—epithelium—allergic rhinitis	0.000999	0.0041	CbGeAlD
Crizotinib—FER—lung—allergic rhinitis	0.000997	0.00409	CbGeAlD
Crizotinib—ALK—lung—allergic rhinitis	0.000997	0.00409	CbGeAlD
Crizotinib—JAK2—bronchus—allergic rhinitis	0.000996	0.00409	CbGeAlD
Crizotinib—TBK1—trachea—allergic rhinitis	0.000989	0.00406	CbGeAlD
Crizotinib—PTK2—trachea—allergic rhinitis	0.000989	0.00406	CbGeAlD
Crizotinib—TNK1—lung—allergic rhinitis	0.000987	0.00405	CbGeAlD
Crizotinib—YES1—eye—allergic rhinitis	0.000984	0.00404	CbGeAlD
Crizotinib—EPHA2—bronchus—allergic rhinitis	0.000984	0.00404	CbGeAlD
Crizotinib—TYK2—trachea—allergic rhinitis	0.000983	0.00404	CbGeAlD
Crizotinib—BMPR1B—lung—allergic rhinitis	0.000977	0.00401	CbGeAlD
Crizotinib—MAP3K19—lung—allergic rhinitis	0.000977	0.00401	CbGeAlD
Crizotinib—MAP4K1—lung—allergic rhinitis	0.000977	0.00401	CbGeAlD
Crizotinib—TEK—epithelium—allergic rhinitis	0.000974	0.004	CbGeAlD
Crizotinib—TAOK3—eye—allergic rhinitis	0.000971	0.00399	CbGeAlD
Crizotinib—JAK2—skin of body—allergic rhinitis	0.000962	0.00395	CbGeAlD
Crizotinib—MAP3K3—bronchus—allergic rhinitis	0.00096	0.00394	CbGeAlD
Crizotinib—TEK—bronchus—allergic rhinitis	0.00096	0.00394	CbGeAlD
Crizotinib—MAP4K5—bronchus—allergic rhinitis	0.00096	0.00394	CbGeAlD
Crizotinib—TNK2—lung—allergic rhinitis	0.000958	0.00393	CbGeAlD
Crizotinib—IGF1R—lung—allergic rhinitis	0.000958	0.00393	CbGeAlD
Crizotinib—RPS6KB1—trachea—allergic rhinitis	0.000952	0.00391	CbGeAlD
Crizotinib—SRC—eye—allergic rhinitis	0.000947	0.00389	CbGeAlD
Crizotinib—LCK—trachea—allergic rhinitis	0.000946	0.00388	CbGeAlD
Crizotinib—MAP4K2—lung—allergic rhinitis	0.000944	0.00388	CbGeAlD
Crizotinib—AXL—trachea—allergic rhinitis	0.000942	0.00387	CbGeAlD
Crizotinib—TIE1—lung—allergic rhinitis	0.000932	0.00383	CbGeAlD
Crizotinib—STK3—lung—allergic rhinitis	0.000932	0.00383	CbGeAlD
Crizotinib—CSF1R—respiratory system—allergic rhinitis	0.00093	0.00382	CbGeAlD
Crizotinib—MAP3K3—skin of body—allergic rhinitis	0.000927	0.00381	CbGeAlD
Crizotinib—EPHB6—bronchus—allergic rhinitis	0.000917	0.00377	CbGeAlD
Crizotinib—AURKA—lung—allergic rhinitis	0.000908	0.00373	CbGeAlD
Crizotinib—SLK—trachea—allergic rhinitis	0.000907	0.00372	CbGeAlD
Crizotinib—TESK1—lung—allergic rhinitis	0.000901	0.0037	CbGeAlD
Crizotinib—EPHB4—trachea—allergic rhinitis	0.0009	0.0037	CbGeAlD
Crizotinib—JAK2—trachea—allergic rhinitis	0.000894	0.00367	CbGeAlD
Crizotinib—YES1—bronchus—allergic rhinitis	0.000886	0.00364	CbGeAlD
Crizotinib—EPHB6—skin of body—allergic rhinitis	0.000886	0.00364	CbGeAlD
Crizotinib—EPHA2—trachea—allergic rhinitis	0.000883	0.00363	CbGeAlD
Crizotinib—STK10—bronchus—allergic rhinitis	0.000878	0.00361	CbGeAlD
Crizotinib—MERTK—lung—allergic rhinitis	0.000876	0.0036	CbGeAlD
Crizotinib—TAOK3—bronchus—allergic rhinitis	0.000875	0.00359	CbGeAlD
Crizotinib—SRC—epithelium—allergic rhinitis	0.000866	0.00356	CbGeAlD
Crizotinib—MAP3K3—trachea—allergic rhinitis	0.000862	0.00354	CbGeAlD
Crizotinib—MAP4K5—trachea—allergic rhinitis	0.000862	0.00354	CbGeAlD
Crizotinib—LIMK2—lung—allergic rhinitis	0.000857	0.00352	CbGeAlD
Crizotinib—NUAK2—lung—allergic rhinitis	0.000854	0.00351	CbGeAlD
Crizotinib—CSF1R—eye—allergic rhinitis	0.00085	0.00349	CbGeAlD
Crizotinib—MAP3K12—lung—allergic rhinitis	0.000848	0.00348	CbGeAlD
Crizotinib—FLT3—lung—allergic rhinitis	0.000848	0.00348	CbGeAlD
Crizotinib—ACVR1—lung—allergic rhinitis	0.000848	0.00348	CbGeAlD
Crizotinib—STK35—lung—allergic rhinitis	0.00083	0.00341	CbGeAlD
Crizotinib—EPHB6—trachea—allergic rhinitis	0.000824	0.00338	CbGeAlD
Crizotinib—SRC—skin of body—allergic rhinitis	0.000823	0.00338	CbGeAlD
Crizotinib—ABL2—lung—allergic rhinitis	0.000809	0.00332	CbGeAlD
Crizotinib—BMP2K—lung—allergic rhinitis	0.000799	0.00328	CbGeAlD
Crizotinib—YES1—trachea—allergic rhinitis	0.000796	0.00327	CbGeAlD
Crizotinib—TAOK3—trachea—allergic rhinitis	0.000786	0.00323	CbGeAlD
Crizotinib—PTK2B—lung—allergic rhinitis	0.000772	0.00317	CbGeAlD
Crizotinib—RIPK2—lung—allergic rhinitis	0.000766	0.00314	CbGeAlD
Crizotinib—CSF1R—bronchus—allergic rhinitis	0.000765	0.00314	CbGeAlD
Crizotinib—EPHA4—lung—allergic rhinitis	0.00074	0.00304	CbGeAlD
Crizotinib—CSF1R—skin of body—allergic rhinitis	0.000739	0.00304	CbGeAlD
Crizotinib—ABL1—respiratory system—allergic rhinitis	0.000735	0.00302	CbGeAlD
Crizotinib—MAP3K2—lung—allergic rhinitis	0.000726	0.00298	CbGeAlD
Crizotinib—PTK2—lung—allergic rhinitis	0.000711	0.00292	CbGeAlD
Crizotinib—TBK1—lung—allergic rhinitis	0.000711	0.00292	CbGeAlD
Crizotinib—TYK2—lung—allergic rhinitis	0.000706	0.0029	CbGeAlD
Crizotinib—IRAK1—lung—allergic rhinitis	0.000697	0.00286	CbGeAlD
Crizotinib—CSF1R—trachea—allergic rhinitis	0.000687	0.00282	CbGeAlD
Crizotinib—RPS6KB1—lung—allergic rhinitis	0.000684	0.00281	CbGeAlD
Crizotinib—FGR—lung—allergic rhinitis	0.00068	0.00279	CbGeAlD
Crizotinib—LCK—lung—allergic rhinitis	0.00068	0.00279	CbGeAlD
Crizotinib—AXL—lung—allergic rhinitis	0.000677	0.00278	CbGeAlD
Crizotinib—ABL1—eye—allergic rhinitis	0.000672	0.00276	CbGeAlD
Crizotinib—SLK—lung—allergic rhinitis	0.000652	0.00268	CbGeAlD
Crizotinib—EPHB4—lung—allergic rhinitis	0.000647	0.00266	CbGeAlD
Crizotinib—JAK2—lung—allergic rhinitis	0.000642	0.00264	CbGeAlD
Crizotinib—EPHA2—lung—allergic rhinitis	0.000635	0.00261	CbGeAlD
Crizotinib—Fluid retention—Dexamethasone—allergic rhinitis	0.000629	0.00236	CcSEcCtD
Crizotinib—Fluid retention—Betamethasone—allergic rhinitis	0.000629	0.00236	CcSEcCtD
Crizotinib—Neuropathy—Betamethasone—allergic rhinitis	0.000622	0.00233	CcSEcCtD
Crizotinib—Neuropathy—Dexamethasone—allergic rhinitis	0.000622	0.00233	CcSEcCtD
Crizotinib—PTK2B—Carbinoxamine—Diphenhydramine—allergic rhinitis	0.000621	0.0761	CbGdCrCtD
Crizotinib—MAP3K3—lung—allergic rhinitis	0.000619	0.00254	CbGeAlD
Crizotinib—MAP4K5—lung—allergic rhinitis	0.000619	0.00254	CbGeAlD
Crizotinib—TEK—lung—allergic rhinitis	0.000619	0.00254	CbGeAlD
Crizotinib—Asthenia—Olopatadine—allergic rhinitis	0.000618	0.00232	CcSEcCtD
Crizotinib—Nausea—Cyproheptadine—allergic rhinitis	0.000616	0.00231	CcSEcCtD
Crizotinib—Oedema—Cetirizine—allergic rhinitis	0.000611	0.00229	CcSEcCtD
Crizotinib—Visual disturbance—Prednisolone—allergic rhinitis	0.000608	0.00228	CcSEcCtD
Crizotinib—Blood alkaline phosphatase increased—Methylprednisolone—allergic rhinitis	0.000608	0.00228	CcSEcCtD
Crizotinib—Infection—Cetirizine—allergic rhinitis	0.000607	0.00227	CcSEcCtD
Crizotinib—ABL1—bronchus—allergic rhinitis	0.000605	0.00248	CbGeAlD
Crizotinib—Asthenia—Diphenhydramine—allergic rhinitis	0.000605	0.00227	CcSEcCtD
Crizotinib—Asthenia—Dimenhydrinate—allergic rhinitis	0.000605	0.00227	CcSEcCtD
Crizotinib—Shock—Cetirizine—allergic rhinitis	0.000601	0.00225	CcSEcCtD
Crizotinib—Oedema—Flunisolide—allergic rhinitis	0.000601	0.00225	CcSEcCtD
Crizotinib—Nervous system disorder—Cetirizine—allergic rhinitis	0.000599	0.00225	CcSEcCtD
Crizotinib—Nausea—Desloratadine—allergic rhinitis	0.000598	0.00224	CcSEcCtD
Crizotinib—Infection—Flunisolide—allergic rhinitis	0.000597	0.00224	CcSEcCtD
Crizotinib—Skin disorder—Cetirizine—allergic rhinitis	0.000593	0.00222	CcSEcCtD
Crizotinib—EPHB6—lung—allergic rhinitis	0.000592	0.00243	CbGeAlD
Crizotinib—Shock—Flunisolide—allergic rhinitis	0.000591	0.00222	CcSEcCtD
Crizotinib—Diarrhoea—Olopatadine—allergic rhinitis	0.000589	0.00221	CcSEcCtD
Crizotinib—ABL1—skin of body—allergic rhinitis	0.000584	0.0024	CbGeAlD
Crizotinib—Paraesthesia—Loratadine—allergic rhinitis	0.000583	0.00219	CcSEcCtD
Crizotinib—Diarrhoea—Dimenhydrinate—allergic rhinitis	0.000577	0.00216	CcSEcCtD
Crizotinib—Diarrhoea—Diphenhydramine—allergic rhinitis	0.000577	0.00216	CcSEcCtD
Crizotinib—YES1—lung—allergic rhinitis	0.000572	0.00235	CbGeAlD
Crizotinib—Dyspepsia—Loratadine—allergic rhinitis	0.000571	0.00214	CcSEcCtD
Crizotinib—Dizziness—Olopatadine—allergic rhinitis	0.00057	0.00214	CcSEcCtD
Crizotinib—STK10—lung—allergic rhinitis	0.000567	0.00233	CbGeAlD
Crizotinib—TAOK3—lung—allergic rhinitis	0.000564	0.00232	CbGeAlD
Crizotinib—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.000561	0.0021	CcSEcCtD
Crizotinib—Fatigue—Loratadine—allergic rhinitis	0.00056	0.0021	CcSEcCtD
Crizotinib—Dizziness—Diphenhydramine—allergic rhinitis	0.000557	0.00209	CcSEcCtD
Crizotinib—Dizziness—Dimenhydrinate—allergic rhinitis	0.000557	0.00209	CcSEcCtD
Crizotinib—Constipation—Loratadine—allergic rhinitis	0.000555	0.00208	CcSEcCtD
Crizotinib—SRC—lung—allergic rhinitis	0.00055	0.00226	CbGeAlD
Crizotinib—Paraesthesia—Cetirizine—allergic rhinitis	0.000549	0.00206	CcSEcCtD
Crizotinib—Vomiting—Olopatadine—allergic rhinitis	0.000548	0.00205	CcSEcCtD
Crizotinib—Dyspnoea—Cetirizine—allergic rhinitis	0.000545	0.00204	CcSEcCtD
Crizotinib—ABL1—trachea—allergic rhinitis	0.000543	0.00223	CbGeAlD
Crizotinib—Rash—Olopatadine—allergic rhinitis	0.000543	0.00204	CcSEcCtD
Crizotinib—Dermatitis—Olopatadine—allergic rhinitis	0.000543	0.00203	CcSEcCtD
Crizotinib—Dyspepsia—Cetirizine—allergic rhinitis	0.000538	0.00202	CcSEcCtD
Crizotinib—Vomiting—Dimenhydrinate—allergic rhinitis	0.000536	0.00201	CcSEcCtD
Crizotinib—Vomiting—Diphenhydramine—allergic rhinitis	0.000536	0.00201	CcSEcCtD
Crizotinib—Dyspnoea—Flunisolide—allergic rhinitis	0.000536	0.00201	CcSEcCtD
Crizotinib—Rash—Diphenhydramine—allergic rhinitis	0.000532	0.00199	CcSEcCtD
Crizotinib—Rash—Dimenhydrinate—allergic rhinitis	0.000532	0.00199	CcSEcCtD
Crizotinib—Decreased appetite—Cetirizine—allergic rhinitis	0.000531	0.00199	CcSEcCtD
Crizotinib—Dermatitis—Dimenhydrinate—allergic rhinitis	0.000531	0.00199	CcSEcCtD
Crizotinib—Dermatitis—Diphenhydramine—allergic rhinitis	0.000531	0.00199	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.000531	0.00199	CcSEcCtD
Crizotinib—Dyspepsia—Flunisolide—allergic rhinitis	0.000529	0.00198	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000527	0.00198	CcSEcCtD
Crizotinib—Fatigue—Cetirizine—allergic rhinitis	0.000527	0.00197	CcSEcCtD
Crizotinib—Constipation—Cetirizine—allergic rhinitis	0.000522	0.00196	CcSEcCtD
Crizotinib—Decreased appetite—Flunisolide—allergic rhinitis	0.000522	0.00196	CcSEcCtD
Crizotinib—Fatigue—Flunisolide—allergic rhinitis	0.000518	0.00194	CcSEcCtD
Crizotinib—Constipation—Flunisolide—allergic rhinitis	0.000514	0.00193	CcSEcCtD
Crizotinib—Body temperature increased—Loratadine—allergic rhinitis	0.000513	0.00192	CcSEcCtD
Crizotinib—Oedema—Montelukast—allergic rhinitis	0.000512	0.00192	CcSEcCtD
Crizotinib—Hypokalaemia—Hydrocortisone—allergic rhinitis	0.000512	0.00192	CcSEcCtD
Crizotinib—Nausea—Olopatadine—allergic rhinitis	0.000512	0.00192	CcSEcCtD
Crizotinib—Infection—Montelukast—allergic rhinitis	0.000509	0.00191	CcSEcCtD
Crizotinib—Muscular weakness—Prednisolone—allergic rhinitis	0.000508	0.00191	CcSEcCtD
Crizotinib—Visual disturbance—Dexamethasone—allergic rhinitis	0.000507	0.0019	CcSEcCtD
Crizotinib—Visual disturbance—Betamethasone—allergic rhinitis	0.000507	0.0019	CcSEcCtD
Crizotinib—Nervous system disorder—Montelukast—allergic rhinitis	0.000502	0.00188	CcSEcCtD
Crizotinib—Nausea—Dimenhydrinate—allergic rhinitis	0.000501	0.00188	CcSEcCtD
Crizotinib—Nausea—Diphenhydramine—allergic rhinitis	0.000501	0.00188	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Flunisolide—allergic rhinitis	0.0005	0.0612	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Flunisolide—allergic rhinitis	0.0005	0.0612	CbGdCrCtD
Crizotinib—Skin disorder—Montelukast—allergic rhinitis	0.000498	0.00187	CcSEcCtD
Crizotinib—Muscular weakness—Hydrocortisone—allergic rhinitis	0.000496	0.00186	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Hydrocortisone—allergic rhinitis	0.000496	0.00186	CcSEcCtD
Crizotinib—CSF1R—lung—allergic rhinitis	0.000494	0.00203	CbGeAlD
Crizotinib—Body temperature increased—Cetirizine—allergic rhinitis	0.000483	0.00181	CcSEcCtD
Crizotinib—Body temperature increased—Flunisolide—allergic rhinitis	0.000475	0.00178	CcSEcCtD
Crizotinib—Muscular weakness—Triamcinolone—allergic rhinitis	0.000467	0.00175	CcSEcCtD
Crizotinib—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.000466	0.00175	CcSEcCtD
Crizotinib—Muscular weakness—Methylprednisolone—allergic rhinitis	0.000466	0.00175	CcSEcCtD
Crizotinib—Asthenia—Loratadine—allergic rhinitis	0.000466	0.00175	CcSEcCtD
Crizotinib—Paraesthesia—Montelukast—allergic rhinitis	0.00046	0.00172	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Hydrocortisone—allergic rhinitis	0.000452	0.00169	CcSEcCtD
Crizotinib—Dyspepsia—Montelukast—allergic rhinitis	0.000451	0.00169	CcSEcCtD
Crizotinib—Diarrhoea—Loratadine—allergic rhinitis	0.000444	0.00167	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000442	0.00166	CcSEcCtD
Crizotinib—Fatigue—Montelukast—allergic rhinitis	0.000442	0.00166	CcSEcCtD
Crizotinib—Weight decreased—Hydrocortisone—allergic rhinitis	0.00044	0.00165	CcSEcCtD
Crizotinib—Asthenia—Cetirizine—allergic rhinitis	0.000438	0.00164	CcSEcCtD
Crizotinib—Hypokalaemia—Betamethasone—allergic rhinitis	0.000438	0.00164	CcSEcCtD
Crizotinib—Hypokalaemia—Dexamethasone—allergic rhinitis	0.000438	0.00164	CcSEcCtD
Crizotinib—Neuropathy peripheral—Prednisolone—allergic rhinitis	0.000435	0.00163	CcSEcCtD
Crizotinib—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000434	0.00163	CcSEcCtD
Crizotinib—Infestation—Hydrocortisone—allergic rhinitis	0.000434	0.00163	CcSEcCtD
Crizotinib—Asthenia—Flunisolide—allergic rhinitis	0.000431	0.00162	CcSEcCtD
Crizotinib—CYP3A5—respiratory system—allergic rhinitis	0.00043	0.00177	CbGeAlD
Crizotinib—Dizziness—Loratadine—allergic rhinitis	0.000429	0.00161	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Triamcinolone—allergic rhinitis	0.000426	0.0016	CcSEcCtD
Crizotinib—Neuropathy peripheral—Hydrocortisone—allergic rhinitis	0.000425	0.00159	CcSEcCtD
Crizotinib—Muscular weakness—Dexamethasone—allergic rhinitis	0.000424	0.00159	CcSEcCtD
Crizotinib—Muscular weakness—Betamethasone—allergic rhinitis	0.000424	0.00159	CcSEcCtD
Crizotinib—Diarrhoea—Cetirizine—allergic rhinitis	0.000418	0.00157	CcSEcCtD
Crizotinib—Vomiting—Loratadine—allergic rhinitis	0.000413	0.00155	CcSEcCtD
Crizotinib—Diarrhoea—Flunisolide—allergic rhinitis	0.000411	0.00154	CcSEcCtD
Crizotinib—Rash—Loratadine—allergic rhinitis	0.000409	0.00153	CcSEcCtD
Crizotinib—Dermatitis—Loratadine—allergic rhinitis	0.000409	0.00153	CcSEcCtD
Crizotinib—Infestation NOS—Methylprednisolone—allergic rhinitis	0.000407	0.00153	CcSEcCtD
Crizotinib—Infestation—Methylprednisolone—allergic rhinitis	0.000407	0.00153	CcSEcCtD
Crizotinib—Bradycardia—Prednisolone—allergic rhinitis	0.000406	0.00152	CcSEcCtD
Crizotinib—Body temperature increased—Montelukast—allergic rhinitis	0.000405	0.00152	CcSEcCtD
Crizotinib—Dizziness—Cetirizine—allergic rhinitis	0.000404	0.00151	CcSEcCtD
Crizotinib—Neuropathy peripheral—Triamcinolone—allergic rhinitis	0.0004	0.0015	CcSEcCtD
Crizotinib—Neuropathy peripheral—Methylprednisolone—allergic rhinitis	0.000399	0.0015	CcSEcCtD
Crizotinib—Dizziness—Flunisolide—allergic rhinitis	0.000397	0.00149	CcSEcCtD
Crizotinib—Bradycardia—Hydrocortisone—allergic rhinitis	0.000396	0.00149	CcSEcCtD
Crizotinib—ABL1—lung—allergic rhinitis	0.00039	0.0016	CbGeAlD
Crizotinib—Vomiting—Cetirizine—allergic rhinitis	0.000388	0.00146	CcSEcCtD
Crizotinib—Nausea—Loratadine—allergic rhinitis	0.000386	0.00145	CcSEcCtD
Crizotinib—Rash—Cetirizine—allergic rhinitis	0.000385	0.00144	CcSEcCtD
Crizotinib—Dermatitis—Cetirizine—allergic rhinitis	0.000385	0.00144	CcSEcCtD
Crizotinib—Visual impairment—Prednisolone—allergic rhinitis	0.000384	0.00144	CcSEcCtD
Crizotinib—Vomiting—Flunisolide—allergic rhinitis	0.000382	0.00143	CcSEcCtD
Crizotinib—Rash—Flunisolide—allergic rhinitis	0.000379	0.00142	CcSEcCtD
Crizotinib—Dermatitis—Flunisolide—allergic rhinitis	0.000378	0.00142	CcSEcCtD
Crizotinib—Weight decreased—Betamethasone—allergic rhinitis	0.000376	0.00141	CcSEcCtD
Crizotinib—Weight decreased—Dexamethasone—allergic rhinitis	0.000376	0.00141	CcSEcCtD
Crizotinib—Bradycardia—Triamcinolone—allergic rhinitis	0.000373	0.0014	CcSEcCtD
Crizotinib—Bradycardia—Methylprednisolone—allergic rhinitis	0.000372	0.0014	CcSEcCtD
Crizotinib—Asthenia—Montelukast—allergic rhinitis	0.000368	0.00138	CcSEcCtD
Crizotinib—Eye disorder—Hydrocortisone—allergic rhinitis	0.000364	0.00136	CcSEcCtD
Crizotinib—Neuropathy peripheral—Dexamethasone—allergic rhinitis	0.000363	0.00136	CcSEcCtD
Crizotinib—Neuropathy peripheral—Betamethasone—allergic rhinitis	0.000363	0.00136	CcSEcCtD
Crizotinib—Nausea—Cetirizine—allergic rhinitis	0.000363	0.00136	CcSEcCtD
Crizotinib—Nausea—Flunisolide—allergic rhinitis	0.000357	0.00134	CcSEcCtD
Crizotinib—Arrhythmia—Prednisolone—allergic rhinitis	0.000356	0.00133	CcSEcCtD
Crizotinib—Visual impairment—Methylprednisolone—allergic rhinitis	0.000353	0.00132	CcSEcCtD
Crizotinib—Diarrhoea—Montelukast—allergic rhinitis	0.000351	0.00131	CcSEcCtD
Crizotinib—Arrhythmia—Hydrocortisone—allergic rhinitis	0.000348	0.0013	CcSEcCtD
Crizotinib—Eye disorder—Methylprednisolone—allergic rhinitis	0.000342	0.00128	CcSEcCtD
Crizotinib—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.00034	0.00127	CcSEcCtD
Crizotinib—Malnutrition—Hydrocortisone—allergic rhinitis	0.000339	0.00127	CcSEcCtD
Crizotinib—Dizziness—Montelukast—allergic rhinitis	0.000339	0.00127	CcSEcCtD
Crizotinib—Bradycardia—Betamethasone—allergic rhinitis	0.000339	0.00127	CcSEcCtD
Crizotinib—Bradycardia—Dexamethasone—allergic rhinitis	0.000339	0.00127	CcSEcCtD
Crizotinib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.00033	0.00124	CcSEcCtD
Crizotinib—Arrhythmia—Triamcinolone—allergic rhinitis	0.000328	0.00123	CcSEcCtD
Crizotinib—Vision blurred—Prednisolone—allergic rhinitis	0.000327	0.00123	CcSEcCtD
Crizotinib—Arrhythmia—Methylprednisolone—allergic rhinitis	0.000327	0.00122	CcSEcCtD
Crizotinib—Vomiting—Montelukast—allergic rhinitis	0.000326	0.00122	CcSEcCtD
Crizotinib—Rash—Montelukast—allergic rhinitis	0.000323	0.00121	CcSEcCtD
Crizotinib—Dermatitis—Montelukast—allergic rhinitis	0.000323	0.00121	CcSEcCtD
Crizotinib—TESK1—Dexamethasone—Flunisolide—allergic rhinitis	0.000322	0.0394	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Flunisolide—allergic rhinitis	0.000322	0.0394	CbGdCrCtD
Crizotinib—Visual impairment—Dexamethasone—allergic rhinitis	0.000321	0.0012	CcSEcCtD
Crizotinib—Visual impairment—Betamethasone—allergic rhinitis	0.000321	0.0012	CcSEcCtD
Crizotinib—Malnutrition—Methylprednisolone—allergic rhinitis	0.000318	0.00119	CcSEcCtD
Crizotinib—Dysgeusia—Triamcinolone—allergic rhinitis	0.000313	0.00117	CcSEcCtD
Crizotinib—Syncope—Prednisolone—allergic rhinitis	0.000311	0.00117	CcSEcCtD
Crizotinib—Eye disorder—Dexamethasone—allergic rhinitis	0.000311	0.00117	CcSEcCtD
Crizotinib—Eye disorder—Betamethasone—allergic rhinitis	0.000311	0.00117	CcSEcCtD
Crizotinib—Loss of consciousness—Prednisolone—allergic rhinitis	0.000305	0.00114	CcSEcCtD
Crizotinib—Nausea—Montelukast—allergic rhinitis	0.000304	0.00114	CcSEcCtD
Crizotinib—Syncope—Hydrocortisone—allergic rhinitis	0.000304	0.00114	CcSEcCtD
Crizotinib—Loss of consciousness—Hydrocortisone—allergic rhinitis	0.000298	0.00112	CcSEcCtD
Crizotinib—Arrhythmia—Betamethasone—allergic rhinitis	0.000297	0.00111	CcSEcCtD
Crizotinib—Arrhythmia—Dexamethasone—allergic rhinitis	0.000297	0.00111	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000287	0.00107	CcSEcCtD
Crizotinib—Syncope—Triamcinolone—allergic rhinitis	0.000286	0.00107	CcSEcCtD
Crizotinib—Syncope—Methylprednisolone—allergic rhinitis	0.000286	0.00107	CcSEcCtD
Crizotinib—Oedema—Prednisolone—allergic rhinitis	0.000283	0.00106	CcSEcCtD
Crizotinib—Loss of consciousness—Triamcinolone—allergic rhinitis	0.000281	0.00105	CcSEcCtD
Crizotinib—Loss of consciousness—Methylprednisolone—allergic rhinitis	0.00028	0.00105	CcSEcCtD
Crizotinib—Shock—Prednisolone—allergic rhinitis	0.000279	0.00104	CcSEcCtD
Crizotinib—Oedema—Hydrocortisone—allergic rhinitis	0.000277	0.00104	CcSEcCtD
Crizotinib—Infection—Hydrocortisone—allergic rhinitis	0.000275	0.00103	CcSEcCtD
Crizotinib—Shock—Hydrocortisone—allergic rhinitis	0.000272	0.00102	CcSEcCtD
Crizotinib—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000271	0.00102	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000269	0.00101	CcSEcCtD
Crizotinib—Skin disorder—Hydrocortisone—allergic rhinitis	0.000269	0.00101	CcSEcCtD
Crizotinib—Oedema—Triamcinolone—allergic rhinitis	0.00026	0.000976	CcSEcCtD
Crizotinib—Syncope—Dexamethasone—allergic rhinitis	0.00026	0.000973	CcSEcCtD
Crizotinib—Syncope—Betamethasone—allergic rhinitis	0.00026	0.000973	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Hydrocortisone—allergic rhinitis	0.000259	0.0317	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Hydrocortisone—allergic rhinitis	0.000259	0.0317	CbGdCrCtD
Crizotinib—Infection—Triamcinolone—allergic rhinitis	0.000259	0.00097	CcSEcCtD
Crizotinib—Infection—Methylprednisolone—allergic rhinitis	0.000258	0.000968	CcSEcCtD
Crizotinib—Shock—Triamcinolone—allergic rhinitis	0.000256	0.000961	CcSEcCtD
Crizotinib—Shock—Methylprednisolone—allergic rhinitis	0.000256	0.000958	CcSEcCtD
Crizotinib—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000255	0.000955	CcSEcCtD
Crizotinib—Loss of consciousness—Betamethasone—allergic rhinitis	0.000255	0.000954	CcSEcCtD
Crizotinib—Loss of consciousness—Dexamethasone—allergic rhinitis	0.000255	0.000954	CcSEcCtD
Crizotinib—Paraesthesia—Prednisolone—allergic rhinitis	0.000254	0.000953	CcSEcCtD
Crizotinib—Skin disorder—Methylprednisolone—allergic rhinitis	0.000252	0.000946	CcSEcCtD
Crizotinib—Paraesthesia—Hydrocortisone—allergic rhinitis	0.000248	0.000931	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Methylprednisolone—allergic rhinitis	0.000245	0.03	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Methylprednisolone—allergic rhinitis	0.000245	0.03	CbGdCrCtD
Crizotinib—Dyspepsia—Hydrocortisone—allergic rhinitis	0.000244	0.000913	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Betamethasone—allergic rhinitis	0.000241	0.0295	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Dexamethasone—allergic rhinitis	0.000241	0.0295	CbGdCrCtD
Crizotinib—Decreased appetite—Hydrocortisone—allergic rhinitis	0.00024	0.000901	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000239	0.000895	CcSEcCtD
Crizotinib—Fatigue—Hydrocortisone—allergic rhinitis	0.000238	0.000894	CcSEcCtD
Crizotinib—Oedema—Dexamethasone—allergic rhinitis	0.000236	0.000886	CcSEcCtD
Crizotinib—Oedema—Betamethasone—allergic rhinitis	0.000236	0.000886	CcSEcCtD
Crizotinib—ACVR1—Betamethasone—Triamcinolone—allergic rhinitis	0.000235	0.0288	CbGdCrCtD
Crizotinib—ACVR1—Dexamethasone—Triamcinolone—allergic rhinitis	0.000235	0.0288	CbGdCrCtD
Crizotinib—Infection—Dexamethasone—allergic rhinitis	0.000235	0.00088	CcSEcCtD
Crizotinib—Infection—Betamethasone—allergic rhinitis	0.000235	0.00088	CcSEcCtD
Crizotinib—Paraesthesia—Triamcinolone—allergic rhinitis	0.000234	0.000877	CcSEcCtD
Crizotinib—Paraesthesia—Methylprednisolone—allergic rhinitis	0.000233	0.000875	CcSEcCtD
Crizotinib—Shock—Betamethasone—allergic rhinitis	0.000233	0.000872	CcSEcCtD
Crizotinib—Shock—Dexamethasone—allergic rhinitis	0.000233	0.000872	CcSEcCtD
Crizotinib—Dyspnoea—Triamcinolone—allergic rhinitis	0.000232	0.00087	CcSEcCtD
Crizotinib—Nervous system disorder—Betamethasone—allergic rhinitis	0.000232	0.000869	CcSEcCtD
Crizotinib—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000232	0.000869	CcSEcCtD
Crizotinib—Dyspepsia—Triamcinolone—allergic rhinitis	0.000229	0.000859	CcSEcCtD
Crizotinib—Dyspepsia—Methylprednisolone—allergic rhinitis	0.000229	0.000858	CcSEcCtD
Crizotinib—ABCB1—respiratory system—allergic rhinitis	0.000229	0.000939	CbGeAlD
Crizotinib—CYP3A5—lung—allergic rhinitis	0.000229	0.000938	CbGeAlD
Crizotinib—Fatigue—Triamcinolone—allergic rhinitis	0.000225	0.000842	CcSEcCtD
Crizotinib—Fatigue—Methylprednisolone—allergic rhinitis	0.000224	0.00084	CcSEcCtD
Crizotinib—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000219	0.00082	CcSEcCtD
Crizotinib—ACVR1—Dexamethasone—Prednisolone—allergic rhinitis	0.000218	0.0267	CbGdCrCtD
Crizotinib—ACVR1—Betamethasone—Prednisolone—allergic rhinitis	0.000218	0.0267	CbGdCrCtD
Crizotinib—Paraesthesia—Dexamethasone—allergic rhinitis	0.000212	0.000795	CcSEcCtD
Crizotinib—Paraesthesia—Betamethasone—allergic rhinitis	0.000212	0.000795	CcSEcCtD
Crizotinib—Dyspepsia—Dexamethasone—allergic rhinitis	0.000208	0.00078	CcSEcCtD
Crizotinib—Dyspepsia—Betamethasone—allergic rhinitis	0.000208	0.00078	CcSEcCtD
Crizotinib—Body temperature increased—Triamcinolone—allergic rhinitis	0.000206	0.000772	CcSEcCtD
Crizotinib—Decreased appetite—Betamethasone—allergic rhinitis	0.000205	0.00077	CcSEcCtD
Crizotinib—Decreased appetite—Dexamethasone—allergic rhinitis	0.000205	0.00077	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000204	0.000765	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000204	0.000765	CcSEcCtD
Crizotinib—Fatigue—Dexamethasone—allergic rhinitis	0.000204	0.000764	CcSEcCtD
Crizotinib—Fatigue—Betamethasone—allergic rhinitis	0.000204	0.000764	CcSEcCtD
Crizotinib—Asthenia—Hydrocortisone—allergic rhinitis	0.000198	0.000744	CcSEcCtD
Crizotinib—ABCB1—epithelium—allergic rhinitis	0.000191	0.000785	CbGeAlD
Crizotinib—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000189	0.000709	CcSEcCtD
Crizotinib—Dizziness—Prednisolone—allergic rhinitis	0.000187	0.000702	CcSEcCtD
Crizotinib—Asthenia—Triamcinolone—allergic rhinitis	0.000187	0.0007	CcSEcCtD
Crizotinib—Body temperature increased—Betamethasone—allergic rhinitis	0.000187	0.0007	CcSEcCtD
Crizotinib—Body temperature increased—Dexamethasone—allergic rhinitis	0.000187	0.0007	CcSEcCtD
Crizotinib—Asthenia—Methylprednisolone—allergic rhinitis	0.000186	0.000699	CcSEcCtD
Crizotinib—Dizziness—Hydrocortisone—allergic rhinitis	0.000183	0.000686	CcSEcCtD
Crizotinib—Rash—Prednisolone—allergic rhinitis	0.000179	0.000669	CcSEcCtD
Crizotinib—Dermatitis—Prednisolone—allergic rhinitis	0.000178	0.000669	CcSEcCtD
Crizotinib—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000178	0.000667	CcSEcCtD
Crizotinib—Vomiting—Hydrocortisone—allergic rhinitis	0.000176	0.000659	CcSEcCtD
Crizotinib—Rash—Hydrocortisone—allergic rhinitis	0.000174	0.000654	CcSEcCtD
Crizotinib—Dermatitis—Hydrocortisone—allergic rhinitis	0.000174	0.000653	CcSEcCtD
Crizotinib—Dizziness—Triamcinolone—allergic rhinitis	0.000172	0.000646	CcSEcCtD
Crizotinib—Dizziness—Methylprednisolone—allergic rhinitis	0.000172	0.000644	CcSEcCtD
Crizotinib—Asthenia—Betamethasone—allergic rhinitis	0.00017	0.000636	CcSEcCtD
Crizotinib—Asthenia—Dexamethasone—allergic rhinitis	0.00017	0.000636	CcSEcCtD
Crizotinib—ABCB1—trachea—allergic rhinitis	0.000169	0.000694	CbGeAlD
Crizotinib—Nausea—Prednisolone—allergic rhinitis	0.000168	0.000631	CcSEcCtD
Crizotinib—TESK1—Dexamethasone—Hydrocortisone—allergic rhinitis	0.000167	0.0205	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Hydrocortisone—allergic rhinitis	0.000167	0.0205	CbGdCrCtD
Crizotinib—Vomiting—Triamcinolone—allergic rhinitis	0.000166	0.000621	CcSEcCtD
Crizotinib—Vomiting—Methylprednisolone—allergic rhinitis	0.000165	0.000619	CcSEcCtD
Crizotinib—Nausea—Hydrocortisone—allergic rhinitis	0.000164	0.000616	CcSEcCtD
Crizotinib—Rash—Triamcinolone—allergic rhinitis	0.000164	0.000616	CcSEcCtD
Crizotinib—Dermatitis—Triamcinolone—allergic rhinitis	0.000164	0.000615	CcSEcCtD
Crizotinib—Rash—Methylprednisolone—allergic rhinitis	0.000164	0.000614	CcSEcCtD
Crizotinib—Dermatitis—Methylprednisolone—allergic rhinitis	0.000164	0.000614	CcSEcCtD
Crizotinib—Diarrhoea—Dexamethasone—allergic rhinitis	0.000162	0.000606	CcSEcCtD
Crizotinib—Diarrhoea—Betamethasone—allergic rhinitis	0.000162	0.000606	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Methylprednisolone—allergic rhinitis	0.000158	0.0193	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Methylprednisolone—allergic rhinitis	0.000158	0.0193	CbGdCrCtD
Crizotinib—Dizziness—Dexamethasone—allergic rhinitis	0.000156	0.000586	CcSEcCtD
Crizotinib—Dizziness—Betamethasone—allergic rhinitis	0.000156	0.000586	CcSEcCtD
Crizotinib—TESK1—Betamethasone—Dexamethasone—allergic rhinitis	0.000155	0.019	CbGdCrCtD
Crizotinib—TESK1—Dexamethasone—Betamethasone—allergic rhinitis	0.000155	0.019	CbGdCrCtD
Crizotinib—Nausea—Triamcinolone—allergic rhinitis	0.000155	0.00058	CcSEcCtD
Crizotinib—Nausea—Methylprednisolone—allergic rhinitis	0.000154	0.000579	CcSEcCtD
Crizotinib—TESK1—Dexamethasone—Triamcinolone—allergic rhinitis	0.000152	0.0186	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Triamcinolone—allergic rhinitis	0.000152	0.0186	CbGdCrCtD
Crizotinib—Vomiting—Betamethasone—allergic rhinitis	0.00015	0.000563	CcSEcCtD
Crizotinib—Vomiting—Dexamethasone—allergic rhinitis	0.00015	0.000563	CcSEcCtD
Crizotinib—Rash—Betamethasone—allergic rhinitis	0.000149	0.000559	CcSEcCtD
Crizotinib—Rash—Dexamethasone—allergic rhinitis	0.000149	0.000559	CcSEcCtD
Crizotinib—Dermatitis—Betamethasone—allergic rhinitis	0.000149	0.000558	CcSEcCtD
Crizotinib—Dermatitis—Dexamethasone—allergic rhinitis	0.000149	0.000558	CcSEcCtD
Crizotinib—TESK1—Dexamethasone—Prednisolone—allergic rhinitis	0.00014	0.0172	CbGdCrCtD
Crizotinib—TESK1—Betamethasone—Prednisolone—allergic rhinitis	0.00014	0.0172	CbGdCrCtD
Crizotinib—Nausea—Betamethasone—allergic rhinitis	0.00014	0.000526	CcSEcCtD
Crizotinib—Nausea—Dexamethasone—allergic rhinitis	0.00014	0.000526	CcSEcCtD
Crizotinib—ABCB1—lung—allergic rhinitis	0.000121	0.000499	CbGeAlD
Crizotinib—CDK7—Disease—SMAD3—allergic rhinitis	4e-05	0.000146	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—ICAM1—allergic rhinitis	3.94e-05	0.000144	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-G—allergic rhinitis	3.93e-05	0.000144	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—CD4—allergic rhinitis	3.86e-05	0.000141	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TAC1—allergic rhinitis	3.85e-05	0.000141	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—IL5—allergic rhinitis	3.82e-05	0.00014	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL5—allergic rhinitis	3.79e-05	0.000139	CbGpPWpGaD
Crizotinib—JAK3—Hemostasis—TGFB1—allergic rhinitis	3.74e-05	0.000137	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL5—allergic rhinitis	3.74e-05	0.000137	CbGpPWpGaD
Crizotinib—LYN—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.73e-05	0.000137	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TAC1—allergic rhinitis	3.73e-05	0.000137	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—TAC1—allergic rhinitis	3.73e-05	0.000136	CbGpPWpGaD
Crizotinib—JAK3—Immune System—ICAM1—allergic rhinitis	3.72e-05	0.000136	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	3.71e-05	0.000136	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—CD4—allergic rhinitis	3.7e-05	0.000135	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—CD4—allergic rhinitis	3.7e-05	0.000135	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—NFKB1—allergic rhinitis	3.67e-05	0.000134	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	3.65e-05	0.000134	CbGpPWpGaD
Crizotinib—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	3.65e-05	0.000133	CbGpPWpGaD
Crizotinib—RIPK2—Innate Immune System—NFKB1—allergic rhinitis	3.6e-05	0.000132	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—TGFB1—allergic rhinitis	3.59e-05	0.000131	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL5—allergic rhinitis	3.58e-05	0.000131	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HLA-DQB1—allergic rhinitis	3.56e-05	0.00013	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HLA-DQB1—allergic rhinitis	3.54e-05	0.00013	CbGpPWpGaD
Crizotinib—YES1—Immune System—HLA-DQB1—allergic rhinitis	3.52e-05	0.000129	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PTGDR2—allergic rhinitis	3.5e-05	0.000128	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—NFKB1—allergic rhinitis	3.5e-05	0.000128	CbGpPWpGaD
Crizotinib—JAK2—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.49e-05	0.000128	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	3.47e-05	0.000127	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL5—allergic rhinitis	3.47e-05	0.000127	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL5—allergic rhinitis	3.47e-05	0.000127	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—NFKB1—allergic rhinitis	3.46e-05	0.000127	CbGpPWpGaD
Crizotinib—FGR—Innate Immune System—NFKB1—allergic rhinitis	3.45e-05	0.000126	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-G—allergic rhinitis	3.44e-05	0.000126	CbGpPWpGaD
Crizotinib—JAK2—Signaling by NGF—NFKB1—allergic rhinitis	3.41e-05	0.000125	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL5—allergic rhinitis	3.39e-05	0.000124	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL5—allergic rhinitis	3.37e-05	0.000123	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—SMAD3—allergic rhinitis	3.36e-05	0.000123	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CYSLTR1—allergic rhinitis	3.35e-05	0.000123	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HLA-DQB1—allergic rhinitis	3.33e-05	0.000122	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—NFKB1—allergic rhinitis	3.33e-05	0.000122	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—ICAM1—allergic rhinitis	3.31e-05	0.000121	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—CD4—allergic rhinitis	3.28e-05	0.00012	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—ICAM1—allergic rhinitis	3.27e-05	0.00012	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CCL11—allergic rhinitis	3.24e-05	0.000119	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—CD4—allergic rhinitis	3.24e-05	0.000118	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-DQB1—allergic rhinitis	3.24e-05	0.000118	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—NFKB1—allergic rhinitis	3.2e-05	0.000117	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TAC1—allergic rhinitis	3.2e-05	0.000117	CbGpPWpGaD
Crizotinib—FGR—Hemostasis—TGFB1—allergic rhinitis	3.2e-05	0.000117	CbGpPWpGaD
Crizotinib—BLK—Immune System—ICAM1—allergic rhinitis	3.19e-05	0.000117	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—NFKB1—allergic rhinitis	3.19e-05	0.000117	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—NFKB1—allergic rhinitis	3.19e-05	0.000117	CbGpPWpGaD
Crizotinib—FGR—Immune System—ICAM1—allergic rhinitis	3.18e-05	0.000116	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL5—allergic rhinitis	3.17e-05	0.000116	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—NFKB1—allergic rhinitis	3.16e-05	0.000116	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TAC1—allergic rhinitis	3.16e-05	0.000116	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—ICAM1—allergic rhinitis	3.15e-05	0.000115	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CYSLTR1—allergic rhinitis	3.14e-05	0.000115	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-DQB1—allergic rhinitis	3.14e-05	0.000115	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—CD4—allergic rhinitis	3.11e-05	0.000114	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PTGDR2—allergic rhinitis	3.1e-05	0.000113	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—NFKB1—allergic rhinitis	3.07e-05	0.000112	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—NFKB1—allergic rhinitis	3.07e-05	0.000112	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—CD4—allergic rhinitis	3.07e-05	0.000112	CbGpPWpGaD
Crizotinib—LCK—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.06e-05	0.000112	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—TGFB1—allergic rhinitis	3.05e-05	0.000112	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-G—allergic rhinitis	3.05e-05	0.000111	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.04e-05	0.000111	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	3.04e-05	0.000111	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CCL11—allergic rhinitis	3.03e-05	0.000111	CbGpPWpGaD
Crizotinib—TBK1—Immune System—CD4—allergic rhinitis	3.02e-05	0.000111	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—SMAD3—allergic rhinitis	3e-05	0.00011	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TAC1—allergic rhinitis	2.99e-05	0.00011	CbGpPWpGaD
Crizotinib—LCK—Signaling by NGF—NFKB1—allergic rhinitis	2.99e-05	0.000109	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—CD4—allergic rhinitis	2.98e-05	0.000109	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL5—allergic rhinitis	2.98e-05	0.000109	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL5—allergic rhinitis	2.94e-05	0.000107	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—NFKB1—allergic rhinitis	2.91e-05	0.000107	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—NFKB1—allergic rhinitis	2.91e-05	0.000106	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TAC1—allergic rhinitis	2.91e-05	0.000106	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—CD4—allergic rhinitis	2.9e-05	0.000106	CbGpPWpGaD
Crizotinib—PTK2—Innate Immune System—NFKB1—allergic rhinitis	2.83e-05	0.000103	CbGpPWpGaD
Crizotinib—YES1—Innate Immune System—NFKB1—allergic rhinitis	2.79e-05	0.000102	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL5—allergic rhinitis	2.78e-05	0.000102	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL5—allergic rhinitis	2.77e-05	0.000102	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CYSLTR1—allergic rhinitis	2.75e-05	0.000101	CbGpPWpGaD
Crizotinib—JAK3—Immune System—CD4—allergic rhinitis	2.73e-05	0.0001	CbGpPWpGaD
Crizotinib—TYK2—Disease—SMAD3—allergic rhinitis	2.72e-05	9.94e-05	CbGpPWpGaD
Crizotinib—SRC—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	2.71e-05	9.91e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL5—allergic rhinitis	2.7e-05	9.89e-05	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—NFKB1—allergic rhinitis	2.68e-05	9.8e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—SMAD3—allergic rhinitis	2.67e-05	9.77e-05	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—TGFB1—allergic rhinitis	2.67e-05	9.76e-05	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—NFKB1—allergic rhinitis	2.66e-05	9.75e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CCL11—allergic rhinitis	2.66e-05	9.72e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—NFKB1—allergic rhinitis	2.65e-05	9.68e-05	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—NFKB1—allergic rhinitis	2.64e-05	9.68e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—SMAD3—allergic rhinitis	2.63e-05	9.63e-05	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—TGFB1—allergic rhinitis	2.63e-05	9.62e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-DQB1—allergic rhinitis	2.62e-05	9.59e-05	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—TGFB1—allergic rhinitis	2.62e-05	9.57e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-DQB1—allergic rhinitis	2.61e-05	9.54e-05	CbGpPWpGaD
Crizotinib—TBK1—Immune System—NFKB1—allergic rhinitis	2.6e-05	9.53e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—ICAM1—allergic rhinitis	2.6e-05	9.52e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—ICAM1—allergic rhinitis	2.58e-05	9.46e-05	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—TGFB1—allergic rhinitis	2.58e-05	9.44e-05	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—NFKB1—allergic rhinitis	2.57e-05	9.39e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—ICAM1—allergic rhinitis	2.57e-05	9.38e-05	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—TGFB1—allergic rhinitis	2.56e-05	9.36e-05	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—TGFB1—allergic rhinitis	2.56e-05	9.36e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—SMAD3—allergic rhinitis	2.52e-05	9.21e-05	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—NFKB1—allergic rhinitis	2.5e-05	9.13e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL5—allergic rhinitis	2.46e-05	8.99e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-DQB1—allergic rhinitis	2.45e-05	8.97e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—SMAD3—allergic rhinitis	2.44e-05	8.93e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—CD4—allergic rhinitis	2.44e-05	8.91e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CYSLTR1—allergic rhinitis	2.43e-05	8.91e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—ICAM1—allergic rhinitis	2.43e-05	8.9e-05	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—TGFB1—allergic rhinitis	2.43e-05	8.88e-05	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—TGFB1—allergic rhinitis	2.42e-05	8.86e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—CD4—allergic rhinitis	2.41e-05	8.83e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—CD4—allergic rhinitis	2.4e-05	8.79e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—CD4—allergic rhinitis	2.4e-05	8.78e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—ICAM1—allergic rhinitis	2.36e-05	8.64e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—CD4—allergic rhinitis	2.36e-05	8.62e-05	CbGpPWpGaD
Crizotinib—JAK3—Immune System—NFKB1—allergic rhinitis	2.35e-05	8.61e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—NFKB1—allergic rhinitis	2.35e-05	8.61e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TAC1—allergic rhinitis	2.35e-05	8.61e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CCL11—allergic rhinitis	2.35e-05	8.6e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—NFKB1—allergic rhinitis	2.34e-05	8.57e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—CD4—allergic rhinitis	2.34e-05	8.57e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—CD4—allergic rhinitis	2.34e-05	8.54e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—NFKB1—allergic rhinitis	2.33e-05	8.52e-05	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—CD4—allergic rhinitis	2.32e-05	8.48e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—ICAM1—allergic rhinitis	2.29e-05	8.37e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—CD4—allergic rhinitis	2.26e-05	8.26e-05	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—TGFB1—allergic rhinitis	2.22e-05	8.12e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—NFKB1—allergic rhinitis	2.2e-05	8.06e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TAC1—allergic rhinitis	2.2e-05	8.06e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL5—allergic rhinitis	2.19e-05	8.01e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.16e-05	7.91e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DQB1—allergic rhinitis	2.15e-05	7.86e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—NFKB1—allergic rhinitis	2.11e-05	7.7e-05	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—NFKB1—allergic rhinitis	2.1e-05	7.68e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—SMAD3—allergic rhinitis	2.09e-05	7.66e-05	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—NFKB1—allergic rhinitis	2.08e-05	7.61e-05	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—NFKB1—allergic rhinitis	2.07e-05	7.57e-05	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—NFKB1—allergic rhinitis	2.07e-05	7.57e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—SMAD3—allergic rhinitis	2.07e-05	7.56e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—NFKB1—allergic rhinitis	2.06e-05	7.54e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—SMAD3—allergic rhinitis	2.06e-05	7.53e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL5—allergic rhinitis	2.05e-05	7.49e-05	CbGpPWpGaD
Crizotinib—BLK—Immune System—NFKB1—allergic rhinitis	2.02e-05	7.39e-05	CbGpPWpGaD
Crizotinib—FGR—Immune System—NFKB1—allergic rhinitis	2.01e-05	7.36e-05	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—NFKB1—allergic rhinitis	2e-05	7.3e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—CD4—allergic rhinitis	1.98e-05	7.24e-05	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—TGFB1—allergic rhinitis	1.96e-05	7.17e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SMAD3—allergic rhinitis	1.96e-05	7.17e-05	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—TGFB1—allergic rhinitis	1.95e-05	7.14e-05	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—NFKB1—allergic rhinitis	1.95e-05	7.12e-05	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—TGFB1—allergic rhinitis	1.94e-05	7.1e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TAC1—allergic rhinitis	1.93e-05	7.06e-05	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—TGFB1—allergic rhinitis	1.92e-05	7.04e-05	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—TGFB1—allergic rhinitis	1.91e-05	7.01e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—ICAM1—allergic rhinitis	1.91e-05	7e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CD4—allergic rhinitis	1.91e-05	6.99e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—ICAM1—allergic rhinitis	1.9e-05	6.97e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SMAD3—allergic rhinitis	1.9e-05	6.96e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DQB1—allergic rhinitis	1.9e-05	6.96e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—CD4—allergic rhinitis	1.9e-05	6.95e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—CD4—allergic rhinitis	1.89e-05	6.9e-05	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—TGFB1—allergic rhinitis	1.84e-05	6.71e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—SMAD3—allergic rhinitis	1.8e-05	6.6e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.8e-05	6.59e-05	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—TGFB1—allergic rhinitis	1.8e-05	6.59e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL5—allergic rhinitis	1.79e-05	6.56e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—ICAM1—allergic rhinitis	1.79e-05	6.55e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CD4—allergic rhinitis	1.79e-05	6.54e-05	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—TGFB1—allergic rhinitis	1.75e-05	6.42e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—CD4—allergic rhinitis	1.75e-05	6.41e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—CD4—allergic rhinitis	1.74e-05	6.35e-05	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—TGFB1—allergic rhinitis	1.72e-05	6.28e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—NFKB1—allergic rhinitis	1.71e-05	6.25e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TAC1—allergic rhinitis	1.71e-05	6.25e-05	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—NFKB1—allergic rhinitis	1.7e-05	6.23e-05	CbGpPWpGaD
Crizotinib—CDK7—Disease—TGFB1—allergic rhinitis	1.69e-05	6.19e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CD4—allergic rhinitis	1.68e-05	6.15e-05	CbGpPWpGaD
Crizotinib—PTK2—Immune System—NFKB1—allergic rhinitis	1.65e-05	6.02e-05	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—NFKB1—allergic rhinitis	1.64e-05	5.99e-05	CbGpPWpGaD
Crizotinib—YES1—Immune System—NFKB1—allergic rhinitis	1.62e-05	5.94e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—CD4—allergic rhinitis	1.6e-05	5.86e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—SMAD3—allergic rhinitis	1.6e-05	5.84e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL5—allergic rhinitis	1.59e-05	5.81e-05	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—TGFB1—allergic rhinitis	1.58e-05	5.77e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—ICAM1—allergic rhinitis	1.57e-05	5.74e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—NFKB1—allergic rhinitis	1.54e-05	5.64e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SMAD3—allergic rhinitis	1.54e-05	5.64e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—NFKB1—allergic rhinitis	1.52e-05	5.57e-05	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—NFKB1—allergic rhinitis	1.51e-05	5.52e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—NFKB1—allergic rhinitis	1.5e-05	5.47e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—NFKB1—allergic rhinitis	1.45e-05	5.3e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SMAD3—allergic rhinitis	1.44e-05	5.27e-05	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TGFB1—allergic rhinitis	1.42e-05	5.21e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD4—allergic rhinitis	1.41e-05	5.14e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD4—allergic rhinitis	1.4e-05	5.12e-05	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—TGFB1—allergic rhinitis	1.4e-05	5.11e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—ICAM1—allergic rhinitis	1.39e-05	5.08e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—NFKB1—allergic rhinitis	1.36e-05	4.96e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—NFKB1—allergic rhinitis	1.34e-05	4.89e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD4—allergic rhinitis	1.32e-05	4.81e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—NFKB1—allergic rhinitis	1.28e-05	4.68e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—TGFB1—allergic rhinitis	1.27e-05	4.64e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SMAD3—allergic rhinitis	1.26e-05	4.62e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—NFKB1—allergic rhinitis	1.24e-05	4.54e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—CD4—allergic rhinitis	1.21e-05	4.44e-05	CbGpPWpGaD
Crizotinib—LYN—Immune System—NFKB1—allergic rhinitis	1.21e-05	4.43e-05	CbGpPWpGaD
Crizotinib—ABL1—Immune System—NFKB1—allergic rhinitis	1.21e-05	4.41e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD4—allergic rhinitis	1.15e-05	4.22e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—TGFB1—allergic rhinitis	1.15e-05	4.21e-05	CbGpPWpGaD
Crizotinib—JAK2—Immune System—NFKB1—allergic rhinitis	1.13e-05	4.15e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—TGFB1—allergic rhinitis	1.13e-05	4.14e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SMAD3—allergic rhinitis	1.12e-05	4.09e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—TGFB1—allergic rhinitis	1.11e-05	4.08e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—TGFB1—allergic rhinitis	1.07e-05	3.9e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—NFKB1—allergic rhinitis	1.06e-05	3.9e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—CD4—allergic rhinitis	1.06e-05	3.89e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—NFKB1—allergic rhinitis	1.05e-05	3.84e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—TGFB1—allergic rhinitis	1.03e-05	3.78e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD4—allergic rhinitis	1.02e-05	3.73e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—NFKB1—allergic rhinitis	9.96e-06	3.64e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—NFKB1—allergic rhinitis	9.93e-06	3.63e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—NFKB1—allergic rhinitis	9.67e-06	3.54e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—CD4—allergic rhinitis	9.42e-06	3.45e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—TGFB1—allergic rhinitis	8.87e-06	3.24e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—NFKB1—allergic rhinitis	8.79e-06	3.21e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—TGFB1—allergic rhinitis	8.75e-06	3.2e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—TGFB1—allergic rhinitis	8.72e-06	3.19e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—TGFB1—allergic rhinitis	8.3e-06	3.04e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—TGFB1—allergic rhinitis	8.05e-06	2.95e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—NFKB1—allergic rhinitis	7.83e-06	2.86e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—TGFB1—allergic rhinitis	7.63e-06	2.79e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—NFKB1—allergic rhinitis	7.33e-06	2.68e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—TGFB1—allergic rhinitis	6.76e-06	2.47e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TGFB1—allergic rhinitis	6.52e-06	2.39e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—NFKB1—allergic rhinitis	6.42e-06	2.35e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TGFB1—allergic rhinitis	6.1e-06	2.23e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—NFKB1—allergic rhinitis	5.68e-06	2.08e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TGFB1—allergic rhinitis	5.35e-06	1.96e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TGFB1—allergic rhinitis	4.73e-06	1.73e-05	CbGpPWpGaD
